Publication dates

All regions

Schizophrenia Industry Statistics

1-7 of about 800 reports for Schizophrenia

Pathology Description Forecast

  • July 2014
    3 pages
  • Schizophrenia  

    Drug  

  • Europe  

    Japan  

    United States  

View report >

Pharmacy Industry in the UK Forecast

  • January 2015
    142 pages
  • Pharmacy  

    Cancer  

  • United Kingdom  

View report >

Pharmaceutical Industry in the UK

  • July 2014
    157 pages
  • Mental Illness  

    Mental Health  

    Drug  

  • United Kingdom  

    Europe  

View report >

Pathology Description in the UK

  • January 2014
    81 pages
  • Mental Health  

    Mental Illness  

  • United Kingdom  

View report >

Pathology Description in the UK

  • May 2014
    34 pages
  • Pathology  

  • United Kingdom  

View report >

Pathology Description in North America

  • January 2014
    232 pages
  • Mental Health  

    Mental Illness  

  • Jamaica  

    North America  

    United Kingdom  

View report >

Pathology Description in Norway and Chile

  • August 2014
    79 pages
  • Mental Illness  

    Mental Health  

  • Norway  

    Chile  

View report >
84 reports for Schizophrenia

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 10 995)

Schizophrenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Schizophrenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Schizophrenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Key Pharma News 05 January 2015

January 2015 $ 1 415


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.